Request access for On-Demand
Welcome
We would like to invite you to our webinar «Management of Patients receiving CAR T Cell Therapy».
Three national speakers will highlight various aspects of secondary immunodeficiencies after a CAR T cell therapy.
To attend the webinar of September 13th 2023, please fill in the form.
For additional information, please contact:
Dr. Stefanie Buschor
Senior Medical Science Liaison
BMS
stefanie.buschor@bms.com
079 657 29 18
Dr. Christoph Schneider
Head of Marketing & Sales
CSL Behring
christoph.schneider@cslbehring.com
079 580 57 49
Note: The webinar is intended for healthcare professionals only.
Your opinion counts!
(1=min, 10=max)
Program
Time | Title | Speaker |
---|---|---|
17:00 –17:05 | Welcome and Introduction of Speakers | Prof. Dr. Dr. med. Sacha Zeerleder, Luzerner Kantonsspital |
17:05 –17:30 | CAR T cell therapies: how they have revolutionized our treatment landscape | Prof. Dr. med. Dr. phil. Dominik Schneidawind, Universitätsspital Zürich |
17:30–17:55 | Secondary immune deficiencies after CAR T cell therapy | Prof. Dr. Dr. med. Sacha Zeerleder, Luzerner Kantonsspital |
17:55–18:15 | Collaboration between referring physician and treatment center | Dr. Jasmine Noetzli, Cabinet Noetzli, Lausanne |
18:15–18:30 | Q&A |
Organized and sponsored by:
Legal notice
CSL Behring and Bristol Myers Squibb have engaged POMCANYS Marketing AG to conduct the webinar/webcast. For information on how your personal data is processed click on the following link for CSL Behring and Bristol Myers Squibb.
Please note that by participating in the webcast it can be concluded that you are entering into a customer relationship with CSL Behring and/or Bristol Myers Squibb.
CSL Behring AG, Wankdorfstrasse 10, CH-3014 Bern / Bristol Myers Squibb SA, Hinterbergstrasse 16, CH-6312 Steinhausen
SUI-IMG-0028/ 07.2023
HE-CH-2300091